- Home
- XAIR
XAIR
Beyond Air Inc.
as 07-26-2024 4:00pm EST
Beyond Air Inc is a clinical-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | GARDEN CITY |
| Market Cap: | 57.4M | IPO Year: | N/A |
| Target Price: | $5.75 | AVG Volume (30 days): | 864.1K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.82 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.53 - $3.90 | Next Earning Date: | 08-08-2024 |
| Revenue: | $1,159,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 1061.26% | Revenue Growth (next year): | 208.60% |
Stock Insider Trading Activity of Beyond Air Inc. (XAIR)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Avniel Amir | XAIR | Chief Business Officer | Dec 28 '23 | Sell | $2.06 | 11,267 | $23,233.68 | 685,760 | SEC Form 4 |
| Avniel Amir | XAIR | Chief Business Officer | Dec 28 '23 | Sell | $2.05 | 13,733 | $28,217.20 | 0 | SEC Form 4 |
| Myers Jeff Lynn | XAIR | Chief Medical Officer | Dec 27 '23 | Sell | $2.21 | 3,423 | $7,578.52 | 46,577 | SEC Form 4 |
| Lisi Steven A. | XAIR | CEO and Chairman of the Board | Dec 18 '23 | Buy | $1.63 | 77,775 | $126,796.58 | 1,536,471 | SEC Form 4 |
| Carey Robert | XAIR | Director | Dec 18 '23 | Buy | $1.64 | 1,200,000 | $1,962,000.00 | 2,374,454 | SEC Form 4 |
Latest Beyond Air Inc. News
XAIR Breaking Stock News: Dive into XAIR Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6
GlobeNewswire
10 days ago
Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024
GlobeNewswire
a month ago
Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
a month ago
Beyond Air® Appoints David Webster as Chief Commercial Officer
PR Newswire
2 months ago
Getting smarter: FIA Launches 3-Day Smart Driving Challenge in Samarkand, Powered by Greater Than
PR Newswire
2 months ago
3 Major Product Releases at 3Shape Discover Event
Business Wire
2 months ago
Net Asset Value(s)
AFP
2 months ago
Irish, Czechs hold EU vote after Dutch far-right gains
Compare XAIR vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XAIR Beyond Air Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.